CHAMPIONS ONCOLOGY, INC. Proceeds from Warrant Exercises
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Proceeds from Warrant Exercises of $3.90 million for the 12-month period ending 2021-04-30, per its 10-K filed 2021-07-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2021-07-26
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for the quarter ending 2013-07-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for the quarter ending 2013-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for the quarter ending 2013-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for the quarter ending 2012-10-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for fiscal 2021 was $3.90M, a 0.00% change from fiscal 2020.
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for fiscal 2020 was $3.90M.
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CHAMPIONS ONCOLOGY, INC. proceeds from warrant exercises for fiscal 2012 was $97.00K, a 361.90% increase from fiscal 2011.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2021-04-30 | $3.90M 10-K · filed 2021-07-26 | |||
| 2020-04-30 | $3.90M 10-K · filed 2020-07-28 | |||
| 2013-07-31 | $0.00 10-Q · filed 2013-09-13 | $0.00 derived: sum of 2 quarters · filed 2013-09-13 | $0.00 derived: sum of 3 quarters · filed 2013-09-13 | $0.00 derived: sum of 4 quarters · filed 2013-09-13 |
| 2013-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | $0.00 derived: sum of 2 quarters · filed 2013-07-26 | $0.00 derived: sum of 3 quarters · filed 2013-07-26 | $0.00 10-K · filed 2013-07-26 |
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | $0.00 derived: sum of 2 quarters · filed 2013-03-13 | $0.00 10-Q · filed 2013-03-13 | -$1.00K derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | $0.00 10-Q · filed 2012-12-13 | -$1.00K derived: sum of 3 quarters · filed 2013-09-13 | -$1.00K derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-07-31 | $0.00 10-Q · filed 2013-09-13 | -$1.00K derived: sum of 2 quarters · filed 2013-09-13 | -$1.00K derived: sum of 3 quarters · filed 2013-09-13 | $93.00K derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-04-30 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | -$1.00K derived: sum of 2 quarters · filed 2013-07-26 | $93.00K derived: sum of 3 quarters · filed 2013-07-26 | $97.00K 10-K · filed 2013-07-26 |
| 2012-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | $94.00K derived: sum of 2 quarters · filed 2013-03-13 | $98.00K 10-Q · filed 2013-03-13 | $117.00K derived: sum of 4 quarters · filed 2013-03-13 |
| 2011-10-31 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | $98.00K 10-Q · filed 2012-12-13 | $117.00K derived: sum of 3 quarters · filed 2012-12-13 | $119.00K derived: sum of 4 quarters · filed 2012-12-13 |
| 2011-07-31 | $4.00K 10-Q · filed 2012-09-12 | $23.00K derived: sum of 2 quarters · filed 2012-09-12 | $25.00K derived: sum of 3 quarters · filed 2012-09-12 | $25.00K derived: sum of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $21.00K derived: sum of 2 quarters · filed 2012-07-18 | $21.00K derived: sum of 3 quarters · filed 2012-07-18 | $21.00K 10-K · filed 2012-07-18 |
| 2011-01-31 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | $2.00K derived: sum of 2 quarters · filed 2012-03-14 | $2.00K 10-Q · filed 2012-03-14 | |
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-14 | $0.00 10-Q · filed 2011-12-14 | ||
| 2010-07-31 | $0.00 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |